Primary outcome
|
Spectrophotometric hemoglobin (SpHb) at 4 months
|
(n = 137/DCC = 72, ECC = 65)
|
12.4
|
(0.8)
|
12.3
|
(0.7)
|
0.1
|
[−0.18, 0.32]
|
0.59
|
Secondary outcome
|
Anemia (SpHb < 11.0 g/dl) (n = 137/DCC = 72, ECC = 65)
|
1
|
(1.4)
|
0
|
(0)
|
1.0
|
[0.96, 1.01]
|
1.00
|
Neonatal jaundice
|
Total serum bilirubin (TsB) (days 3-5) a (n = 132/DCC = 70, ECC = 62)
|
12.9
|
(3.4)
|
12.0
|
(3.5)
|
0.9
|
[−0.33, 2.08]
|
0.15
|
Over the excess level of transcutaneous bilirubin (TsB) b (n = 132/DCC = 70, ECC = 62)
|
7
|
(10.0)
|
4
|
(6.5)
|
1.6
|
[0.48, 5.04]
|
0.54
|
Phototherapy c (n = 133/DCC = 70, ECC = 63)
|
8
|
(11.4)
|
4
|
(6.3)
|
1.8
|
[0.57, 5.69]
|
0.38
|
Hematocrit
|
Hematocrit level (days 3-5) (%) a (n = 131/DCC = 69, ECC = 62)
|
57.0
|
(5.1)
|
52.4
|
(5.2)
|
4.6
|
[2.84, 6.41]
|
< 0.01*
|
High hematocrit (Hct≧65%) (n = 131/DCC = 69, ECC = 62)
|
3
|
(4.3)
|
2
|
(3.2)
|
0.7
|
[0.12, 4.54]
|
1.00
|